Incretins Beef Up Pancreas (CME/CE)
(MedPage Today) -- Incretin therapy increased pancreatic mass and beta cell mass in patients with type 2 diabetes, potentially putting patients at risk for malignancies, researchers found.
Source: MedPage Today Cardiovascular - Category: Cardiology Source Type: news
More News: Cancer & Oncology | Cardiology | Cardiovascular | Diabetes | Diabetes Type 2 | Endocrinology | Heart | Incretin Therapy | Pancreas